Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1988;34(5):465-8.
doi: 10.1007/BF01046703.

Interaction between furosemide and the converting enzyme inhibitor benazepril in healthy volunteers

I De Lepeleire  1 , A Van Hecken, R Verbesselt, G Kaiser, A Barner, I Holmes, P J De Schepper
Affiliations
Clinical Trial

Interaction between furosemide and the converting enzyme inhibitor benazepril in healthy volunteers

I De Lepeleire et al. Eur J Clin Pharmacol. 1988.

Abstract

Single oral doses of 10 mg converting enzyme inhibitor benazepril (CGS 14824A) and 40 mg furosemide were administered to 12 healthy male volunteers either separately or concomitantly. The pharmacokinetic parameters of benazepril were not influenced by coadministration of furosemide. Urinary excretion of total furosemide was significantly reduced by 10 to 20% in the presence of benazepril. This effect was considered clinically insignificant. Erect blood pressure decreased and pulse rate increased only during concomitant treatment.

PubMed Disclaimer

References

    1. Clin Pharmacol Ther. 1987 May;41(5):580-6 - PubMed
    1. Eur J Clin Pharmacol. 1984;27(5):595-602 - PubMed
    1. Eur J Clin Pharmacol. 1985;28(3):267-72 - PubMed
    1. Metabolism. 1983 Jul;32(7):711-6 - PubMed
    1. Acta Pharmacol Toxicol (Copenh). 1981 Sep;49(3):223-9 - PubMed

Publication types